Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex

[1]  M. Diana,et al.  Clozapine potently stimulates mesocortical dopamine neurons. , 1999, European journal of pharmacology.

[2]  H. Meltzer,et al.  Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. , 1999, The Journal of pharmacology and experimental therapeutics.

[3]  D. Wong,et al.  Olanzapine: a basic science update , 1999, British Journal of Psychiatry.

[4]  P. Goldman-Rakic,et al.  The cerebral cortex: a case for a common site of action of antipsychotics. , 1998, Trends in pharmacological sciences.

[5]  D. Wong,et al.  Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum , 1998, Psychopharmacology.

[6]  Anne W. Schmidt,et al.  Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation. , 1997, European journal of pharmacology.

[7]  F. Borsini,et al.  BIMG 80, a Novel Potential Antipsychotic Drug: Evidence for Multireceptor Actions and Preferential Release of Dopamine in Prefrontal Cortex , 1997, Journal of neurochemistry.

[8]  E. Pehek.  Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex , 1996, Synapse.

[9]  K. Rasmussen,et al.  Electrophysiological Effects of Olanzapine, a Novel Atypical Antipsychotic, on A9 and A10 Dopamine Neurons , 1996, Neuropsychopharmacology.

[10]  L. Steardo,et al.  New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine , 1995, Neuropsychopharmacology.

[11]  C. J. Schmidt,et al.  The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. , 1995, European journal of pharmacology.

[12]  M. L. Pucak,et al.  Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[13]  E. Pehek,et al.  Differential Effects of Locally Administered Clozapine and Haloperidol on Dopamine Efflux in the Rat Prefrontal Cortex and Caudate‐Putamen , 1994, Journal of neurochemistry.

[14]  Douglas W. Jones,et al.  The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[16]  B. Bunney,et al.  Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[17]  J. Tepper,et al.  Mesocortical dopaminergic neurons. 1. Electrophysiological properties and evidence for soma-dendritic autoreceptors , 1989, Brain Research Bulletin.

[18]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[19]  P. Groves,et al.  Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices , 1988, Brain Research.

[20]  R. Roth,et al.  Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors , 1987, Neuropharmacology.

[21]  Timothy H. Hand,et al.  Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons , 1987, Brain Research.

[22]  R. Oades,et al.  Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity , 1987, Brain Research Reviews.

[23]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  T. Dennis,et al.  Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways , 1984, Brain Research.

[25]  G. Gessa,et al.  Evidence for dopamine autoreceptors in mesocortical dopamine neurons , 1984, Brain Research.

[26]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.

[27]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[28]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  J. Lipski,et al.  Antidromic activation of neurones as an analytic tool in the study of the central nervous system , 1981, Journal of Neuroscience Methods.

[30]  R. Roth,et al.  Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. , 1981, Molecular pharmacology.

[31]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[32]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[33]  D. Oh,et al.  Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia. , 1997, Pharmacological research.

[34]  A. Deutch.  The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[35]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[36]  S. Snyder,et al.  The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.

[37]  S. Stahl,et al.  The dopamine hypothesis of schizophrenia: a review. , 1976, Schizophrenia bulletin.

[38]  S. Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.